A commentary on Adolf Eichmann's Rorschach

A Rorschach was administered to Adolf Eichmann in Jerusalem in 1961 at the time of his trial for war crimes. The recent publication of this protocol offers an opportunity to compare his personal world against opinions formed about him by observers at his trial. Various professionals certified Eichmann as a banal, ordinary man, and a societal theory was proposed about Nazism based in part on impressions of Eichmann as an uncomplicated man. This commentary examines Eichmann's protocol and provides an opinion that in several important respects his record includes features uncharacteristic of an ordinary, banal mind.     

Conceptions of Man and the Helping Professions

The helping professions are defined and the argument is advanced that because they are dealing with existential affairs, practitioners must rely more on values than on science. An image of man is proposed and the implications of this image for the work of those in the helping profession indicated.     

Cost Sharing and Hereditary Cancer Risk: Predictors of Willingness-to-Pay for Genetic Testing

Increasing use of predictive genetic testing to gauge hereditary cancer risk has been paralleled by rising cost-sharing practices. Little is known about how demographic and psychosocial factors may influence individuals’ willingness-to-pay for genetic testing. The Gastrointestinal Tumor Risk Assessment Program Registry includes individuals presenting for genetic risk assessment based on personal/family cancer history. Participants complete a baseline survey assessing cancer history and psychosocial items. Willingness-to-pay items include intention for: genetic testing only if paid by insurance; testing with self-pay; and amount willing-to-pay ($25–$2,000). Multivariable models examined predictors of willingness-to-pay out-of-pocket (versus only if paid by insurance) and willingness-to-pay a smaller versus larger sum (≤$200 vs. ≥$500). All statistical tests are two-sided (α?=?0.05). Of 385 evaluable participants, a minority (42 %) had a personal cancer history, while 56 % had ≥1 first-degree relative with colorectal cancer. Overall, 21.3 % were willing to have testing only if paid by insurance, and 78.7 % were willing-to-pay. Predictors of willingness-to-pay were: 1) concern for positive result; 2) confidence to control cancer risk; 3) fewer perceived barriers to colorectal cancer screening; 4) benefit of testing to guide screening (all p?p?相似文献